Literature DB >> 27569070

The role of magnetic resonance imaging in the evaluation of endometrial carcinoma.

Aleksandra Aracki-Trenkic1, Dragan Stojanov, Aleksandra Petric, Daniela Benedeto-Stojanov, Milan Trenkic, Jelena Ignjatovic.   

Abstract

PURPOSE: Gynecological cancers comprise about 19% of all cancers in women whereas the endometrial cancer is the most common malignant tumor of the female reproductive organs. The application of modern imaging tools plays an important role in the preoperative assessment of disease extent and allows the selection of a proper and adequate therapeutic approach for each patient. The purpose of this review was to show the role of magnetic resonance imaging (MRI) in the evaluation of endometrial carcinoma. MRI enables the display of zonal anatomy of the uterus, detection of the anomalies as well as the detection and characterization of pathological processess. Endometrial cancer is staged with the International Federation of Gynecology and Obstetrics (FIGO) classification, which was significantly revised in 2009. The FIGO classification incorporates two of the important prognostic parameters, the depth of myometrial invasion and histological grade. The depth of myometrial invasion can be accurately assessed by MRI. MRI is not officially included in the FIGO staging system. However, it is widely accepted as a suitable imaging technique for preoperative staging, treatment planning and monitoring of patients with endometrial cancer.

Entities:  

Mesh:

Year:  2016        PMID: 27569070

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  1 in total

1.  A Diagnostic Algorithm using Multi-parametric MRI to Differentiate Benign from Malignant Myometrial Tumors: Machine-Learning Method.

Authors:  Mahrooz Malek; Elnaz Tabibian; Milad Rahimi Dehgolan; Maryam Rahmani; Setareh Akhavan; Shahrzad Sheikh Hasani; Fatemeh Nili; Hassan Hashemi
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.